Previous 10 | Next 10 |
SEATTLE, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal second quarter ended August 31, 2023. “We are halfway through the 2024 fiscal year and the demand environment for our solutions remains strong. Accolade continues...
Sumitomo Heavy Industries Ltd. ADR (SOHVY) is expected to report for Q1 2024 Art's-Way Manufacturing Co. Inc. (ARTW) is expected to report for Q2 2024 Resources Connection Inc. (RGP) is expected to report $0.12 for Q1 2024 Bullfrog AI Holdings Inc. (BFRG) is expected to report for Q1 ...
Accolade Inc. (ACCD) is expected to report $-0.56 for Q2 2024
2023-10-03 17:35:33 ET More on Accolade Accolade: Consider Both Growth And Profitability Accolade: Leveraging Tech To Deliver Accessible Healthcare Accolade: Growth Reacceleration In FY25 Should Drive Valuation Upside Seeking Alpha’s Quant Rating on Ac...
2023-10-03 17:35:26 ET ACCD For Seeking Alpha's full earnings season calendar, click here . For further details see: Notable earnings after Wednesday's close
2023-10-03 05:44:05 ET Summary Accolade is in a good position to meet its revenue growth guidance for both the current fiscal year and long term. There is a risk that ACCD's bottom line could fall short of expectations in subsequent quarters, and investors might be concerned about...
2023-09-29 15:00:29 ET More on the markets Historical Evidence Between Real Yields Suggests Further Slump For SPY Interest Rates Won't Be Higher For Longer: SPY Implications Rate environment today 'rhymes with 2008' - J.P. Morgan's Kolanovic Stocks in midst o...
SEATTLE, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves millions of members, today announced that it will release fiscal second quarter 2024 financial results on Wednesday, October 4, 2023, after the market closes. In conjunction, the comp...
Accolade Expands Physician-Executive Leadership to Enhance Care Delivery and Improve the Healthcare Experience PR Newswire Welcomes Dr. Connie Hwang as chief medical officer, creates roles of chief health officer and chief nursing officer SEATTLE , Sept....
SEATTLE, Sept. 06, 2023 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Sept. 5, 2023 by Accolade, Inc. (NASDAQ: ACCD), please note that in the second bullet, the time of the Morgan Stanley presentation should be 1:35 pm ET, not 8:10 am ET as previously stated. The correct...
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / July 21, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 15, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...
NEW YORK, NY / ACCESSWIRE / July 11, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Accolade, Inc. ("Accolade" or "the Company") (NASDAQ:ACCD). Investors who purchased Accolade securities are encouraged to obtain additional information ...